Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
6.42
-0.09 (-1.38%)
Sep 4, 2025, 11:02 AM - Market open
Ardelyx Market Cap
Ardelyx has a market cap or net worth of $1.55 billion as of September 4, 2025. Its market cap has increased by 12.33% in one year.
Market Cap
1.55B
Enterprise Value
1.56B
1-Year Change
12.33%
Ranking
Category
Stock Price
$6.42
Market Cap Chart
Since June 19, 2014, Ardelyx's market cap has increased from $242.70M to $1.55B, an increase of 537.46%. That is a compound annual growth rate of 17.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 1.57B | 30.64% |
| Dec 31, 2024 | 1.20B | -16.56% |
| Dec 29, 2023 | 1.44B | 169.38% |
| Dec 30, 2022 | 534.30M | 330.89% |
| Dec 31, 2021 | 124.00M | -78.76% |
| Dec 31, 2020 | 583.90M | 23.68% |
| Dec 31, 2019 | 472.10M | 324.55% |
| Dec 31, 2018 | 111.20M | -64.55% |
| Dec 29, 2017 | 313.70M | -53.30% |
| Dec 30, 2016 | 671.70M | 42.82% |
| Dec 31, 2015 | 470.30M | 34.29% |
| Dec 31, 2014 | 350.20M | 44.29% |
| Jun 19, 2014 | 242.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 254.41B |
| AstraZeneca | 248.96B |
| Novartis AG | 245.38B |
| Abbott Laboratories | 230.89B |